Helicobacter pylori and type 1 diabetes mellitus: Possibility of modifying chronic disease susceptibility with vaccinomics at the anvil

OMICS A Journal of Integrative Biology

Volumn 15, Issue 9, 2011, Pages 589-596

  Avasthi, Tiruvayipati Suma ^a   Ahmed, Niyaz ^a,b,c  

^a UNIVERSITY OF HYDERABAD   (India)

^b INSTITUTE OF LIFE SCIENCES   (India)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HELICOBACTER PYLORI VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC RESISTANCE; ANTIBODY RESPONSE; BIOMICS; CELLULAR IMMUNITY; CHRONIC DISEASE; DISEASE PREDISPOSITION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INSULIN DEPENDENT DIABETES MELLITUS; MICROBIAL COMMUNITY; MICROFLORA; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; VACCINOMICS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 1; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; VACCINES, DNA; VIRULENCE FACTORS;

HELICOBACTER PYLORI;

EID: 80052691360     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2010.0138     Document Type: Review

References (73)

1. Agarwal, K., and Agarwal, S. (2008). Helicobacter pylori vaccine: from past to future. Mayo Clinic Proc 83, 169-175. (Pubitemid 351303101)
2. Akhiani, A.A., Schon, K., Franzen, L.E., Pappo, J., and Lycke, N. (2004). H. pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. J Immunol 172, 5024-5033. (Pubitemid 38456429)
3. Angelakopoulos, H., and Hohmann, E.L. (2000). Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 68, 2135-2141. (Pubitemid 30164846)
4. Backert, S., and Selbach M. (2008). Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol 10, 1573-1581. (Pubitemid 352006141)
5. Backert, S., Tegtmeyer, N., and Selbach, M. (2010). The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter 15, 163-176.
6. Barrio, R., Roldan, M.B., Alonso, M., Canton, R., and Camarero, C. (1997). Helicobacter pylori infection with parietal cell antibodies in children and adolescents with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 10, 511-516.
7. Begue, R.E., Mirza, A., Compton, T., Gomez, R., and Vargas, A. (1999). Helicobacter pylori infection and insulin requirement among children with type 1 diabetes mellitus. Pediatrics 103, e83.
8. Bener, A., Micallef, R., Afifi, M., Derbala, M., Al-Mulla, H.M., and Usmani, M.A. (2007). Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol 18, 225-229. (Pubitemid 351676975)
9. Bennis, L.D., Boillot, J., Bardin, C., Zirinis, P., Coste, A., Escudier, E., et al. (2001). Six month administration of gelified intranasal insulin in 16 type 1 diabetic patients under multiple injections: efficacy vs subcutaneous injections and local tolerance. Diabetes Metab 27, 372-377. (Pubitemid 32625391)
10. Blanchard, T.G., Eisenberg, J.C., and Matsumoto, Y. (2004). Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy. Vaccine 22, 888-897. (Pubitemid 38177390)
11. Bumann, D., Metzger, W.G., Mansouri, E., Palme, O., Wendland, M., Hurwitz, R., et al. (2001). Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 20, 845-852. (Pubitemid 34015824)
12. Challacombe, S.J., Rahman, D., Jeffery, H., Davis, S.S., and O'Hagen, D.T. (1992). Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76, 164-168.
13. Chinn, S.J., and Nedrud, J.G. (1999). Working towards a Helicobacter pylori vaccine. Gastroenterology 116, 990-993.
14. Corthesy-Theulaz, I.E., Hopkins, S., Bachmann, D., Saldinger, P.F., Porta, N., Haas, R., et al. (1998). Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun 66, 581-586. (Pubitemid 28074198)
15. Czinn, S.J., and Nedrud, J.G. (1991). Oral immunization against Helicobacter pylori. Infect Immun 59, 2359-2363.
16. Das, J.C., and Paul, N. (2007). Epidemiology and pathophysiology of Helicobacter pylori infection in children. Indian J Pediatr 74, 287-290. (Pubitemid 47305152)
17. D'Elios, M.M., Appelmelk, B.J., Amedei, A., Bergman, M.P., and Del Prete G. (2004). Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med 10, 316-323. (Pubitemid 38881520)
18. DiPetrillo, M.D., Tibbetts, T., Kleanthous, H., Killeen, K.P., and Hohman, E.L. (1999). Safety and immunogenicity of phoP/ phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine 18, 449-459. (Pubitemid 29462601)
19. Dubois, A., Berg, D.E., Incecik, E.T., Fiala, N., Heman-Ackah, L.M., Perez-Perez, G.I. et al. (1996). Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease. Infect Immun 64, 2885-2891. (Pubitemid 26256120)
20. Dubois, A., Lee, C.K., Fiala, N., Kleanthous, H., Mehlman, P.T., and Monath, T. (1998). Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect Immun 66, 4340-4346. (Pubitemid 28402710)
21. Elson, C.O., and Ealding, W. (1984). Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 132, 2736-2741. (Pubitemid 14105650)
22. Ferrero, R.L., Thiberge, J.M., Huerre, M., and Labigne, A. (1994). Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect Immun 62, 4981-4989. (Pubitemid 24332805)
23. Ferrero, R.L., Thiberge, J.M., Kansau, I., Wuscher, N., Huerre, M., and Labigne, A. (1995). The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 92, 6499-6503.
24. Ferrero, R.L., Thiberge, J.M., and Labigne, A. (1997). Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice. Gastroenterology 113, 185-194. (Pubitemid 27281773)
25. Fischer, B., Elias, D., Bretzel, R.G., and Linn, T. (2010). Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes-an update. Expert Opin Biol Ther 10, 265-272.
26. Franceschi, F., and Gasbarrini, A. (2007). Helicobacter pylori and extragastric diseases. Best Pract Res Clin Gastroenterol 21, 325-334. (Pubitemid 46421908)
27. Genta, R.M. (1997). The immunobiology of Helicobacter pylori gastritis. Semin Gastrointest Dis 8, 2-11. (Pubitemid 27045980)
28. Gomez-Duarte, O.G., Lucas, B., Yan, Z.X., Panthel, K., Haas, R., and Meyer, T.F. (1998). Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine 16, 460-471. (Pubitemid 28044163)
29. Gottwein, J.M., Blanchard, T.G., Targoni, O.S., Eisenberg, J.C., Zagorski, B.M., Redline, R.W., et al. (2001). Protective anti- Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization. J Infect Dis 184, 308-314. (Pubitemid 32662177)
30. Ha, N.C., Oh, S.T., Sung, J.Y., Cha, K.A., Lee, M.H., and Oh, B.H. (2001). Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat Struct Biol 8, 505-509. (Pubitemid 32525008)
31. Hinke, S.A. (2008). Diamyd, an alum-formulated recombinant human GAD65 for the prevention of autoimmune diabetes. Curr Opin Mol Ther 10, 516-525.
32. Hoffelner, H., and Haas, R. (2004). Recombinant bacterial ghosts: versatile targeting vehicles and promising vaccine candidates. Int J Med Microbiol 294, 303-311. (Pubitemid 39381967)
33. Huppmann, M., Baumgarten, A., Ziegler, A.G., and Bonifacio, E. (2005). Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes. Diabetes Care 28, 1204-1206. (Pubitemid 40616636)
34. Kavermann, H., Burns, B.P., Angermuller, K., Odenbreit, S., Fischer, W., Melchers, K., et al. (2003). Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med 197, 813-822. (Pubitemid 36437859)
35. Khalifa, M.M., Sharaf, R.R., and Aziz, R.K. (2010). Helicobacter pylori: a poor man's gut pathogen? Gut Pathogens 2, 2.
36. Kim, S.Y., Doh, H.J., Ahn, J.S., Ha, Y.J., Jang, M.H., Chung, S.I., et al. (1999). Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly (D,L-lactide-co- glycolide) microparticles. Vaccine 17, 607-633.
37. Lee, K.H., Cho, M.J., Yamaoka, Y., Graham DY, Yun YJ, Woo SY, et al. (2004). Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin- 8 in MKN45 cells. J Clin Microbiol 42, 3518-3524. (Pubitemid 39045675)
38. Leunk, R.D., Johnson, P.T., David, B.C., Kraft, W.G., and Morgan, D.R. (1988). Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 26, 93-99.
39. Londono-Arcila, P., Freeman, D., Kleanthous, H., O'Dowd, A.M., Lewis, S., Turner, A.K., et al. (2002). Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect Immun 70, 5096-5106.
40. Lu, H., Yamaoka, Y., and Graham, D.Y. (2005). Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol 21, 653-659. (Pubitemid 41578639)
41. Ludvigsson, J. (2010). GAD-alum (Diamyd)-a new concept for preservation of residual insulin secretion. Expert Opin Biol Ther 10, 787-799.
42. Lycke, N., and Holmgren, J. (1986). Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin. Scand J Immunol 23, 611-616. (Pubitemid 16086593)
43. Malfertheiner, P., Schultze, V., Giudice, G., Rosenkranz, B., Kaufmann, S.H.E., Winau, F., et al. (2002). Phase I safety and immunogenicity of a three-component H. pylori vaccine. Gastroenterology 122(Suppl.1), A585.
44. Maloy, K.J., Donachie, A.M., O'Hagan, D.T., and Mowat, A.M. (1994). Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly (lactideco- glycolide) microparticles. Immunology 81, 661-667. (Pubitemid 24246520)
45. Mazurkiewicz, P., Tang, C.M., Boone, C., and Holden, D.W. (2006). Signature-tagged mutagenesis: barcoding mutants for genome-wide screens. Nat Rev Genet 7, 929-939. (Pubitemid 44871396)
46. Michetti, P., Kreiss, C., Kotloff, K.L., Porta, N., Blanco, J.L., Bachmann, D., et al. (1999). Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116, 804-812. (Pubitemid 29153528)
47. Nedrud, J.G., Liang, X.P., Hague, N., and Lamm, M.E. (1987). Combined oral/nasal immunization protects mice from Sendai virus infection. J Immunol 139, 3484-3492. (Pubitemid 18022005)
48. Ojetti, V., Pitocco, D., Bartolozzi, F., Danese, S., Migneco, A., Lupascu, A., et al. (2002). High rate of Helicobacter pylori reinfection in patients affected by type 1 diabetes. Diabetes Care 25, 1485.
49. Ottemann, K.M., and Lowenthal, A.C. (2002). Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun 70, 1984-1990. (Pubitemid 34242199)
50. Overbergh, L., Decallonne, B., Waer, M., Rutgeerts, O., Valckx, D., Casteels, K.M., et al. (2000). 1alpha, 25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 8, 1301-1307. (Pubitemid 30624229)
51. Papamichael, K.X., Papaioannou, G., Karga, H., Roussos, A., and Mantzaris, G.J. (2009). Helicobacter pylori infection and endocrine disorders: is there a link? World J Gastroenterol 15, 2701-2707.
52. Pappo, J., Torrey, D., Castriotta, L., Savinainen, A., Kabok, Z., and Ibragimov, A. (1999). Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun 67, 337-341. (Pubitemid 29021667)
53. Poland, G.A., Ovsyannikova, I.G., Jacobson, R.M., and Smith, D.I. (2007). Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 82, 653-664. (Pubitemid 350114830)
54. Poland, G.A., Ovsyannikova, I.G., and Jacobson, R.M. (2008). Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 8, 1659-1667.
55. Rinaudo, C.D., Telford, J.L., Rappuoli, R., and Seib, K.L. (2009). Vaccinology in the genome era. J Clin Invest 119, 2515-2525.
56. Robinson, K., Argent, R.H., and Atherton, J.C. (2007).The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 21, 237-259. (Pubitemid 46436732)
57. Rossi, G., Ruggiero, P., Peppoloni, S., Pancotto, L., Fortuna, D., Lauretti, L., et al. (2004). Therapeutic vaccination against Helicobacter pylori in the Beagle Dog experimental model: safety, immunogenecity and efficacy. Infect Immun 72, 3252-3259. (Pubitemid 38697746)
58. Ryu, S., Kodama, S., Ryu, K., Schoenfeld, D.A., and Faustman, D.L. (2001). Reversal of established autoimmune diabetes by restoration of endogenous b cell function. J Clin Invest 108, 63-72. (Pubitemid 32634923)
59. Schalk, J.A., Mooi, F.R., Berbers, G.A., van Aerts, L.A., Ovelgonne, H., and Kimman, T.G. (2006). Preclinical and clinical safety studies on DNA vaccines. Hum Vaccines 2, 45-53. (Pubitemid 43927157)
60. Seib, K.L., Dougan, G., and Rappuoli, R. (2010). The key role of genomics in modern vaccine and drug design for emerging infectious diseases. PLOS Genet 5, e1000612.
61. Sun, B., Li, Z.S., Tu, Z.X., Xu, G.M., and Du, Y.Q. (2006). Construction of an oral recombinant DNA vaccine from H pylori neutrophil activating protein and its immunogenicity. World J Gastroenterol 12, 7042-7046. (Pubitemid 44834899)
62. Sutton, P. (2001). Progress in vaccination against Helicobacter pylori. Vaccine 19, 2286-2290. (Pubitemid 32234229)
63. Sutton, P., and Lee, A. (2000). Review article: Helicobacter pylori vaccines-the current status. Alimen Pharmacol Ther 14, 1107-1118.
64. Talebkhan, Y., Bababeik, M., Esmaeili, M., Oghalaei, A., Saberi, S., Karimi, Z., et al. (2010). Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccine. J Microbiol Methods 82, 334-337.
65. Tanahasi, T., Kita, M., Kodama, T., Yamaoka, Y., Sawai, N., Ohno, T., et al. (2000). Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells. Infect Immun 68, 664-671. (Pubitemid 30056521)
66. Thomas, C., and Moridani, M. (2009). Interindividual variations in the efficacy and toxicity of vaccines. Toxicology 278, 204-210.
67. Tighe, H., Corr, M., Roman, M., and Raz, E. (1998). Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 19, 89-97. (Pubitemid 28097655)
68. Tsai, S., Shameli, A., Yamanouchi, J., Clemente-Casares, X., Wang, J., Serra, P., et al. (2010). Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 32, 568-580.
69. Velin, D., Bachmann, D., Bouzourene, H., and Michetti, P. (2005). Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 129, 142-155. (Pubitemid 41002051)
70. Wang, G., Wilson, T.J.M., Jiang, Q., and Taylor, D.E. (2001). Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori. Antimicrob Agents Chemother 45, 727-733. (Pubitemid 32182016)
71. Wotherspoon, A.C., Doglioni, C., Diss, T.C., Pan, L., Moschini, A., De Boni, M., et al. (1993). Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575-577. (Pubitemid 23259233)
72. Wyatt, J.I., Rathbone, B.J., and Heatley, R.V. (1986). Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol 39, 863-870. (Pubitemid 16045351)
73. Xu, C., Li, Z.S., Du, Y.Q., Gong, Y.F., Yang, H., Sun, B., et al. (2007). Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H. pylori ureB and IL-2. World J Gastroenterol 13, 939-944. (Pubitemid 46470309)